MYREALWORLD™ MG
SCIENTIFIC
ADVISORY BOARD
Sponsored by Vitaccess, the MyRealWorld™ MG international, observational study of the impact of myasthenia gravis was guided by an expert Scientific Advisory Board. It comprised clinicians and patient advocacy organizations with support from patient-reported outcomes and technical experts. Please note that as of May 2024, the MyRealWorld MG study is closed.
CHAIR
CLINICAL LEADS
PATIENT ADVOCACY GROUPS
GERMANY
Simone Westerhoff (DMG)











